busulfan has been researched along with Rhabdomyosarcoma in 5 studies
Rhabdomyosarcoma: A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Whenever one patient at one dosage level showed a grade III or grade IV reversible toxicity, additional patients were admitted (one by one) up to a maximum number of 6." | 2.69 | Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors. ( Bella, S; Burnelli, R; Garaventa, A; Locatelli, F; Melchionda, F; Paolucci, G; Pession, A; Prete, A, 1999) |
| "The most common primary cancer was acute lymphoblastic leukemia (22 patients, 31." | 1.56 | Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital. ( Kazukawa, I; Kihara, M; Minagawa, M; Mori, K; Shimazaki, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimazaki, S | 1 |
| Kazukawa, I | 1 |
| Mori, K | 1 |
| Kihara, M | 1 |
| Minagawa, M | 1 |
| Mitchell, PL | 1 |
| Shepherd, VB | 1 |
| Proctor, HM | 1 |
| Dainton, M | 1 |
| Cabral, SD | 1 |
| Pinkerton, CR | 1 |
| Pession, A | 1 |
| Prete, A | 1 |
| Locatelli, F | 1 |
| Bella, S | 1 |
| Melchionda, F | 1 |
| Garaventa, A | 1 |
| Burnelli, R | 1 |
| Paolucci, G | 1 |
| Diaz, MA | 1 |
| Vicent, MG | 1 |
| Madero, L | 1 |
| Rodin, AE | 1 |
| Haggard, ME | 1 |
| Travis, LB | 1 |
2 trials available for busulfan and Rhabdomyosarcoma
| Article | Year |
|---|---|
Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; C | 1999 |
High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Agents, Alkylating; Blood Cell Count; Bone Disease | 1999 |
3 other studies available for busulfan and Rhabdomyosarcoma
| Article | Year |
|---|---|
Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Busulfan; Cancer Survivors; Child; Chroni | 2020 |
Peripheral blood stem cells used to augment autologous bone marrow transplantation.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; | 1994 |
Lung changes and chemotherapeutic agents in childhood. Report of a case associated with cyclophosphamide therapy.
Topics: Autopsy; Busulfan; Child, Preschool; Cortisone; Cyclophosphamide; Humans; Hyaline Membrane Disease; | 1970 |